Regular Article
Inhibition of Coumarin 7-Hydroxylase Activity in Human Liver Microsomes,☆☆,

https://doi.org/10.1006/abbi.1997.9964Get rights and content

Abstract

Nine organic solvents and 47 commonly used P450 substrates and inhibitors were examined for their effects on coumarin 7-hydroxylase (CYP2A6) activity in human liver microsomes. Of the nine organic solvents examined (final concentration 1%, v/v), only methanol did not inhibit the 7-hydroxylation of coumarin (0.5 to 50 μm) by human liver microsomes. Dioxane and tetrahydrofuran, which are structurally related to coumarin, were the most inhibitory solvents examined. Although the rates of coumarin 7-hydroxylation varied enormously among nine samples of human liver microsomes and cDNA-expressed CYP2A6 (Vmax= 179 to 2470 pmol/mg protein/min), theKmfor coumarin 7-hydroxylation was fairly constant (ranging from 0.50 to 0.70 μm). The following chemicals caused little or no inhibition of CYP2A6 as defined by aKi> 200 μm: caffeine, chlorzoxazone, cimetidine, dextromethorphan, diazepam, diclofenac, erythromycin, ethinylestradiol, ethynyltestosterone, fluconazole, furafylline, furfural, hexobarbital, itraconazole, mephenytoin, methimazole, metronidazole, naringenin, naringin, nifedipine, norfloxacin, norgestrel, orphenadrine, quinidine, papaverine, phenacetin, pyrimethamine, ranitidine, spironolactone, sulfaphenazole, sulfinpyrazone, testosterone, tolbutamide, troleandomycin, and warfarin. In other words, these chemicals, at a final concentration of 100 μm, failed to inhibit CYP2A6 when the concentration of coumarin was equal toKm(0.50 μm). The following chemicals were classified as strong inhibitors of CYP2A6 (defined byKi< 200 μm): clotrimazole, diethyldithiocarbamate, ellipticine, ketoconazole, 8-methoxypsoralen, 4-methylpyrazole, metyrapone, miconazole, α-naphthoflavone, nicotine,p-nitrophenol, and tranylcypromine. The potency with which each chemical inhibited the 7-hydroxylation of coumarin was independent of which sample of human liver microsomes was studied. One of the most potent inhibitors of coumarin 7-hydroxylase was 8-methoxypsoralen (methoxsalen), which was determined to be a mechanism-based inhibitor (suicide substrate) of CYP2A6 (kinactivation0.5 min−1). With the exception of 8-methoxypsoralen, preincubation of human liver microsomes and NADPH with the aforementioned inhibitors did not increase their ability to inhibit CYP2A6. The most potent competitive inhibitor of CYP2A6 was tranylcypromine (Ki= 0.04 μm). Several of the chemicals that strongly inhibited CYP2A6, such as ketoconazole and tranylcypromine, are often used with the intention of selectively inhibiting human P450 enzymes other than CYP2A6. The results of this study underscore the need for a systematic evaluation of the specificity of commonly used P450 inhibitors.

References (59)

  • D.G. Paris et al.

    Am. J. Emerg. Med.

    (1994)
  • T.K.H. Chang et al.

    Arch. Biochem. Biophys.

    (1994)
  • D.J. Waxman et al.

    Arch. Biochem. Biophys.

    (1991)
  • R.E. Pearce et al.

    Arch. Biochem. Biophys.

    (1992)
  • A.Y.H. Lu et al.

    Biochem. Biophys. Res. Commun.

    (1972)
  • M.S. Ching et al.

    Biochem. Pharmacol.

    (1995)
  • J. Maenpaa et al.

    Biochem. Pharmacol.

    (1994)
  • J. Maenpaa et al.

    Biochem. Pharmacol.

    (1993)
  • D.C. Mays et al.

    Biochem. Pharmacol.

    (1989)
  • J.R. Halpert et al.

    Toxicol. Appl. Pharmacol.

    (1994)
  • D.E. Feierman et al.

    Biochem. Pharmacol.

    (1987)
  • W. Tassaneeyakul et al.

    Biochem. Pharmacol.

    (1993)
  • J.O. Miners et al.

    Biochem. Pharmacol.

    (1988)
  • R.G. Knodell et al.

    Gastroenterology

    (1991)
  • H. Yamazaki et al.

    Biochem. Pharmacol.

    (1994)
  • S. Yamano et al.

    Nucleic Acids Res.

    (1989)
  • J.S. Miles et al.

    Biochem. J.

    (1990)
  • S. Kimura et al.

    Biochemistry

    (1989)
  • S. Yamano et al.

    Biochemistry

    (1990)
  • P.K. Honig et al.

    Clin. Pharmacol. Ther.

    (1992)
  • K.E. Biglin et al.

    Ann. Pharmacother.

    (1994)
  • A. Parkinson

    Casarett and Doull's Toxicology: The Basic Science of Poisons

    (1996)
  • S.A. Wrighton et al.

    Crit. Rev. Toxicol.

    (1992)
  • A. Draper et al.

    Toxicologist

    (1995)
  • C.L. Crespi et al.

    Carcinogenesis

    (1990)
  • M. Maurice et al.

    Eur. J. Biochem.

    (1991)
  • C.-H. Yun et al.

    Mol. Pharmacol.

    (1991)
  • 1991, 1, 16, Pierce Chemical Company, Rockford,...
  • W.F. Greenlee et al.

    J. Pharmacol. Exp. Ther.

    (1978)
  • Cited by (0)

    This work was supported by Grant ES03765 from the National Institutes of Health (NIH). A.J.D. was supported by NIH Training Grant ES07079.

    ☆☆

    A preliminary account of this work was presented in abstract form: A. Draper and A. Parkinson, 1995,Toxicologist15,601.

    C. D. Klaassen, Ed.

    3

    To whom correspondence should be addressed. Fax: (913) 588-7330.

    View full text